These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31287785)

  • 1. Examination of a group entry model into alcohol and other drug (AOD) treatment: Improvements in attendance, retention, and clinical capacity.
    Sander K; Wilson H; Kelly J; Bligh A
    Subst Abus; 2020; 41(1):19-23. PubMed ID: 31287785
    [No Abstract]   [Full Text] [Related]  

  • 2. Relationship between waiting time and retention in treatment amongst substance abusers.
    Addenbrooke WM; Rathod NH
    Drug Alcohol Depend; 1990 Nov; 26(3):255-64. PubMed ID: 2265593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing waiting time for substance abuse treatment does not reduce attrition.
    Alterman AI; Bedrick J; Howden D; Maany I
    J Subst Abuse; 1994; 6(3):325-32. PubMed ID: 7703709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics.
    Ledgerwood DM; Alessi SM; Hanson T; Godley MD; Petry NM
    J Appl Behav Anal; 2008; 41(4):517-26. PubMed ID: 19192856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Client-reported reasons for non-engagement in drug and alcohol treatment.
    Coulson C; Ng F; Geertsema M; Dodd S; Berk M
    Drug Alcohol Rev; 2009 Jul; 28(4):372-8. PubMed ID: 19594791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment dropout as a function of treatment delay and client variables.
    Festinger DS; Lamb RJ; Kountz MR; Kirby KC; Marlowe D
    Addict Behav; 1995; 20(1):111-5. PubMed ID: 7785476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attendance and substance use outcomes for the Seeking Safety program: sometimes less is more.
    Hien DA; Morgan-Lopez AA; Campbell AN; Saavedra LM; Wu E; Cohen L; Ruglass L; Nunes EV
    J Consult Clin Psychol; 2012 Feb; 80(1):29-42. PubMed ID: 22182262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratifying delays for assessment by type of substance to improve the probability of attendance in outpatient services.
    Simioni N; Rolland B; Labreuche J; Ramdane N; Cottencin O
    Drug Alcohol Depend; 2016 Sep; 166():187-93. PubMed ID: 27465970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-treatment expectations in clients: impact on retention and effectiveness in outpatient substance abuse treatment.
    Kuusisto K; Knuuttila V; Saarnio P
    Behav Cogn Psychother; 2011 May; 39(3):257-71. PubMed ID: 21489349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Montreal Cognitive Assessment (MoCA) is Sensitive to Head Injury and Cognitive Impairment in a Residential Alcohol and Other Drug Therapeutic Community.
    Marceau EM; Lunn J; Berry J; Kelly PJ; Solowij N
    J Subst Abuse Treat; 2016 Jul; 66():30-6. PubMed ID: 27211994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal changes in alcohol and drug use among men seen at a gay-specific substance abuse treatment agency.
    Paul JP; Barrett DC; Crosby GM; Stall RD
    J Stud Alcohol; 1996 Sep; 57(5):475-85. PubMed ID: 8858545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 12-Step participation reduces medical use costs among adolescents with a history of alcohol and other drug treatment.
    Mundt MP; Parthasarathy S; Chi FW; Sterling S; Campbell CI
    Drug Alcohol Depend; 2012 Nov; 126(1-2):124-30. PubMed ID: 22633367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solving the problem of non-attendance in substance abuse services.
    Milward J; Lynskey M; Strang J
    Drug Alcohol Rev; 2014 Nov; 33(6):625-36. PubMed ID: 25196817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An abstinence-oriented program for substance use disorders: poorer outcome associated with opiate dependence.
    Paraherakis A; Charney DA; Palacios-Boix J; Gill K
    Can J Psychiatry; 2000 Dec; 45(10):927-31. PubMed ID: 11190363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Street youth in substance abuse treatment: characteristics and treatment compliance.
    Smart RG; Ogborne AC
    Adolescence; 1994; 29(115):733-45. PubMed ID: 7832037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. "Hello, may we help you?" A study of attrition prevention at the time of the first phone contact with substance-abusing clients.
    Stark MJ; Campbell BK; Brinkerhoff CV
    Am J Drug Alcohol Abuse; 1990; 16(1-2):67-76. PubMed ID: 2330937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retention in substance abuse treatment. Role of psychiatric symptom severity.
    Ross HE; Cutler M; Sklar SM
    Am J Addict; 1997; 6(4):293-303. PubMed ID: 9398927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exposure to Adolescent Community Reinforcement Approach treatment procedures as a mediator of the relationship between adolescent substance abuse treatment retention and outcome.
    Garner BR; Godley SH; Funk RR; Dennis ML; Smith JE; Godley MD
    J Subst Abuse Treat; 2009 Apr; 36(3):252-64. PubMed ID: 18715742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Domains of variables for understanding and improving retention in therapeutic communities.
    Condelli WS
    Int J Addict; 1994 Apr; 29(5):593-607. PubMed ID: 8034374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of contracting and prompting substance abuse treatment entry: a pilot trial.
    Lash SJ; Gilmore JD; Burden JL; Weaver KR; Blosser SL; Finney ML
    Addict Behav; 2005 Mar; 30(3):415-22. PubMed ID: 15718059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.